MedTrace Logo

A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

NCT05503927 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1139

Last updated 2026-01-14

No results posted yet for this study

Summary

This is an observational, retrospective, cohort study using administrative insurance claims data. The aim of this non-interventional study (NIS) is to compare maternal, fetal and infant outcomes of women exposed to Wegovy during pregnancy to a reference population not exposed to Wegovy, so that participants and healthcare providers can make informed treatment decisions.

Conditions

Interventions

OTHER

No Intervention

This is a non-interventional study, therefore no intervention is used.

Sponsors & Collaborators

Principal Investigators

  • (dept. 2834) · Novo Nordisk A/S

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-02
Primary Completion
2027-08-15
Completion
2027-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05503927 on ClinicalTrials.gov